{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:47:36Z","timestamp":1777895256681,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2015\/17\/B\/NZ5\/00292"],"award-info":[{"award-number":["2015\/17\/B\/NZ5\/00292"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2015\/17\/B\/NZ5\/00292"],"award-info":[{"award-number":["2015\/17\/B\/NZ5\/00292"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Iron deficiency (ID) commonly occurs in chronic heart failure (HF) and is associated with poor prognosis. Neither its causes nor pathophysiological significance are clearly understood. We aimed to assess iron status and the effect of iron supplementation in the rat model of post-myocardial infarction (MI) HF. Four weeks after induction of MI to induce HF or sham surgery, rats received intravenous iron (ferric carboxymaltose) or saline, 4 doses in 1-week intervals. HF alone did not cause anemia, systemic or myocardial ID, but reduced myocardial ferritin, suggesting depleted cardiomyocyte iron stores. Iron therapy increased serum Fe, ferritin and transferrin saturation as well as cardiac and hepatic iron content in HF rats, but did not increase myocardial ferritin. This was accompanied by: (1) better preservation of left ventricular (LV) ejection fraction and smaller LV dilation, (2) preservation of function of Ca<jats:sup>2+<\/jats:sup> handling proteins in LV cardiomyocytes and (3) reduced level of inflammatory marker, CRP. Furthermore, iron supplementation did not potentiate oxidative stress or have toxic effects on cardiomyocyte function, but increased activity of antioxidant defenses (cardiac superoxide dismutase). Despite lack of systemic or myocardial ID we found evidence of depleted cardiomyocyte iron stores in the rat model of HF. Furthermore we observed positive effect of iron supplementation and confirmed safety of iron supplementation in this setting.<\/jats:p>","DOI":"10.1038\/s41598-018-33277-2","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T10:01:27Z","timestamp":1539943287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Beneficial effects of intravenous iron therapy in a rat model of heart failure with preserved systemic iron status but depleted intracellular cardiac stores"],"prefix":"10.1038","volume":"8","author":[{"given":"Aleksandra","family":"Paterek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"K\u0119pska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Sochanowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Chajduk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Ko\u0142odziejczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halina","family":"Polkowska-Motrenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Kruszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemys\u0142aw","family":"Leszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urszula","family":"Mackiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3157-4141","authenticated-orcid":false,"given":"Micha\u0142","family":"M\u0105czewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"33277_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","volume":"165","author":"IT Klip","year":"2013","unstructured":"Klip, I. T. et al. Iron deficiency in chronic heart failure: An international pooled analysis. Am. Heart J. 165, 575\u2013582 (2013).","journal-title":"Am. Heart J."},{"key":"33277_CR2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","volume":"34","author":"EA Jankowska","year":"2013","unstructured":"Jankowska, E. A. et al. Iron status in patients with chronic heart failure. Eur. Heart J. 34, 827\u2013834 (2013).","journal-title":"Eur. Heart J."},{"key":"33277_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijcard.2015.01.006","volume":"182","author":"P Leszek","year":"2010","unstructured":"Leszek, P. et al. Does myocardial iron load determine the severity of heart insufficiency? Int. J. Cardiol. 182, 191\u2013193 (2010).","journal-title":"Int. J. Cardiol."},{"key":"33277_CR4","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.jacc.2013.02.012","volume":"61","author":"A Khechaduri","year":"2013","unstructured":"Khechaduri, A., Bayeva, M., Chang, H.-C. & Ardehali, H. Heme Levels are Increased in Human Failing Hearts. J. Am. Coll. Cardiol. 61, 1884\u20131893 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33277_CR5","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","volume":"31","author":"EA Jankowska","year":"2010","unstructured":"Jankowska, E. A. et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur. Heart J. 31, 1872\u20131880 (2010).","journal-title":"Eur. Heart J."},{"key":"33277_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","volume":"58","author":"DO Okonko","year":"2011","unstructured":"Okonko, D. O., Mandal, A. K. J., Missouris, C. G. & Poole-Wilson, P. A. Disordered Iron Homeostasis in Chronic Heart Failure. J. Am. Coll. Cardiol. 58, 1241\u20131251 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33277_CR7","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/ejhf.473","volume":"18","author":"EA Jankowska","year":"2016","unstructured":"Jankowska, E. A. et al. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur. J. Heart Fail. 18, 786\u2013795 (2016).","journal-title":"Eur. J. Heart Fail."},{"key":"33277_CR8","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","volume":"124","author":"DT Kremastinos","year":"2011","unstructured":"Kremastinos, D. T. & Farmakis, D. Iron Overload Cardiomyopathy in Clinical Practice. Circulation 124, 2253\u20132263 (2011).","journal-title":"Circulation"},{"key":"33277_CR9","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.116.309746","volume":"119","author":"H-C Chang","year":"2016","unstructured":"Chang, H.-C., Shapiro, J. S. & Ardehali, H. Getting to the \u201cHeart\u201d of Cardiac Disease by Decreasing Mitochondrial Iron. Circ. Res. 119, 1164\u20131166 (2016).","journal-title":"Circ. Res."},{"key":"33277_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ejhf.640","volume":"19","author":"V Melenovsky","year":"2017","unstructured":"Melenovsky, V. et al. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur. J. Heart Fail. 19, 522\u2013530 (2017).","journal-title":"Eur. J. Heart Fail."},{"key":"33277_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.15252\/emmm.201505748","volume":"8","author":"HC Chang","year":"2016","unstructured":"Chang, H. C. et al. Reduction in mitochondrial iron alleviates cardiac damage during injury. EMBO Mol. Med. 8, 247\u2013267 (2016).","journal-title":"EMBO Mol. Med."},{"key":"33277_CR12","first-page":"362","volume":"38","author":"S Haddad","year":"2017","unstructured":"Haddad, S. et al. Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. Eur. Heart J. 38, 362\u2013372 (2017).","journal-title":"Eur. Heart J."},{"key":"33277_CR13","first-page":"474","volume":"58","author":"MT Maeder","year":"2011","unstructured":"Maeder, M. T., Khammy, O., Dos Remedios, C. & Kaye, D. M. Myocardial and Systemic Iron Depletion in Heart Failure. Implications for Anemia Accompanying Heart Failure 58, 474\u2013480 (2011).","journal-title":"Implications for Anemia Accompanying Heart Failure"},{"key":"33277_CR14","doi-asserted-by":"publisher","first-page":"H1406","DOI":"10.1152\/ajpheart.1991.260.5.H1406","volume":"260","author":"JM Pfeffer","year":"1991","unstructured":"Pfeffer, J. M., Pfeffer, M. A., Fletcher, P. J. & Braunwald, E. Progressive ventricular remodeling in rat with myocardial infarction. Am. J. Physiol. HCP 260, H1406\u2013H1414 (1991).","journal-title":"Am. J. Physiol. HCP"},{"key":"33277_CR15","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker, S. D. et al. Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. N. Engl J Med. 361, 2436\u20132448 (2009).","journal-title":"N. Engl J Med."},{"key":"33277_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski, P. et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur. Heart J. 36, 657\u2013668 (2015).","journal-title":"Eur. Heart J."},{"key":"33277_CR17","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1001\/jama.2017.5427","volume":"317","author":"GD Lewis","year":"2017","unstructured":"Lewis, G. D. et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: The ironout hf randomized clinical trial. JAMA 317, 1958\u20131966 (2017).","journal-title":"JAMA"},{"issue":"5","key":"33277_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10741-012-9340-0","volume":"18","author":"Mariana G. Rosca","year":"2012","unstructured":"Rosca, M. G. & Hoppel, C. L. Mitochondrial dysfunction in heart failure. Heart Fail. Rev. 18, https:\/\/doi.org\/10.1007\/s10741-012-9340-0 (2013).","journal-title":"Heart Failure Reviews"},{"key":"33277_CR19","doi-asserted-by":"publisher","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","volume":"301","author":"H Tsutsui","year":"2011","unstructured":"Tsutsui, H., Kinugawa, S. & Matsushima, S. Oxidative stress and heart failure. Am. J. Physiol. HCP 301, H2181\u2013H2190 (2011).","journal-title":"Am. J. Physiol. HCP"},{"key":"33277_CR20","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1073\/pnas.261708798","volume":"99","author":"PB Walter","year":"2002","unstructured":"Walter, P. B. et al. Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. Proc. Natl. Acad. Sci. 99, 2264\u20132269 (2002).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"33277_CR21","doi-asserted-by":"publisher","first-page":"e2475","DOI":"10.1038\/cddis.2016.372","volume":"7","author":"W Wu","year":"2016","unstructured":"Wu, W. et al. Mitochondrial ferritin protects the murine myocardium from acute exhaustive exercise injury. Cell Death & Disease 7, e2475 (2016).","journal-title":"Cell Death & Disease"},{"key":"33277_CR22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/oxfordjournals.eurheartj.a015268","volume":"18","author":"B Devaux","year":"1997","unstructured":"Devaux, B., Scholz, D., Hirche, A., Kl\u00f6vekorn, W. P. & Schaper, J. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur. Heart J. 18, 470\u2013479 (1997).","journal-title":"Eur. Heart J."},{"key":"33277_CR23","first-page":"605","volume":"20","author":"G Weiss","year":"2002","unstructured":"Weiss, G. et al. Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp. Hematol. 20, 605\u2013610 (2002).","journal-title":"Exp. Hematol."},{"key":"33277_CR24","doi-asserted-by":"publisher","first-page":"H960","DOI":"10.1152\/ajpheart.0718.2001","volume":"284","author":"AM Janczewski","year":"2003","unstructured":"Janczewski, A. M. et al. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-\u03b1. Am. J. Physiol. HCP 284, H960\u2013H969 (2003).","journal-title":"Am. J. Physiol. HCP"},{"key":"33277_CR25","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3324\/haematol.2012.072314","volume":"98","author":"H Nam","year":"2013","unstructured":"Nam, H. et al. IP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders. Haematologica 98, 1049\u20131057 (2013).","journal-title":"Haematologica"},{"key":"33277_CR26","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nm920","volume":"9","author":"GY Oudit","year":"2003","unstructured":"Oudit, G. Y. et al. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat. Med. 9, 1187\u20131194 (2003).","journal-title":"Nat. Med."},{"key":"33277_CR27","first-page":"1302","volume":"84","author":"RG Tsushima","year":"1999","unstructured":"Tsushima, R. G. et al. Modulation of Iron Uptake in Heart by L-Type Ca2+ Channel Modifiers. Possible Implications in Iron Overload 84, 1302\u20131309 (1999).","journal-title":"Possible Implications in Iron Overload"},{"key":"33277_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.biochi.2016.05.011","volume":"127","author":"X Li","year":"2016","unstructured":"Li, X., Li, W., Gao, Z. & Li, H. Association of cardiac injury with iron-increased oxidative and nitrative modifications of the SERCA2a isoform of sarcoplasmic reticulum Ca(2+)-ATPase in diabetic rats. Biochimie 127, 144\u2013152 (2016).","journal-title":"Biochimie"},{"key":"33277_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep44460","volume":"7","author":"S Wongjaikam","year":"2017","unstructured":"Wongjaikam, S., Kumfu, S., Khamseekaew, J., Chattipakorn, S. C. & Chattipakorn, N. Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine. Sci. Rep. 7, 44460, https:\/\/doi.org\/10.1038\/srep44460 (2017).","journal-title":"Sci. Rep."},{"key":"33277_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/cvr\/cvn057","volume":"79","author":"M M\u0105czewski","year":"2008","unstructured":"M\u0105czewski, M. & Mackiewicz, U. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart. Cardiovasc. Res. 79, 42\u201351 (2008).","journal-title":"Cardiovasc. Res."},{"key":"33277_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cardfail.2006.03.005","volume":"12","author":"M M\u0105czewski","year":"2006","unstructured":"M\u0105czewski, M. & M\u0105czewska, J. Hypercholesterolemia Exacerbates Ventricular Remodeling in the Rat Model of Myocardial Infarction. J. Card. Fail. 12, 399\u2013405 (2006).","journal-title":"J. Card. Fail."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33277-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33277-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33277-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:43:47Z","timestamp":1671619427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33277-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["33277"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-33277-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]},"assertion":[{"value":"28 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15758"}}